• Events
  • Road to Commercialization Symposium Series: How to Accelerate your Commercialization Success with Non-Dilutive Funding

Road to Commercialization Symposium Series: How to Accelerate your Commercialization Success with Non-Dilutive Funding

Date & Time

Thursday, April 13, 2023, 9:30 a.m.-12:00 p.m.

Category

Innovation

Information

Attendance is required for researchers seeking TechAdvance® and HealthAdvance® funding.

Webinar infographic

Join us for the next webinar of the Road to Commercialization Symposium Series!

The topic: How to Accelerate your Commercialization Success with Non-Dilutive Funding.

Non-dilutive funding allows innovators to maximize their equity or ownership. Learn about this financing option and the resources Innovation Ventures and the Office for Research provide, and hear from founders and researchers who have successfully secured non-dilutive funding and launched startups.

KEYNOTE SPEAKER

Headshot of RenewCO2 CEO Anders Laursen

ANDERS LAURSEN, PHD
Co-Founder and CEO, RenewCO₂

Anders Laursen holds a PhD in surface science from the Technical University of Denmark. He has conducted extensive research in catalysis and electrolysis for hydrogen production and CO₂ conversion for over 15 years and his expertise in these areas forms the basis of his vision for RenewCO₂’s impact in reimagining the chemical industry as a renewable and circular solution. He was recently inducted into the highly competitive Breakthrough Energy Fellowship cohort.
 

FOLLOWING THE KEYNOTE TALK, THERE WILL BE A PANEL DISCUSSION ON NON-DILUTIVE FUNDING. THE WEBINAR WILL CONCLUDE WITH SHORT SESSIONS FOCUSING ON RESOURCES AT INNOVATION VENTURES AND THE OFFICE FOR RESEARCH, INCLUDING NEW VENTURES, I-CORPS, AND COMMERCIALIZATION FUNDING.

PANELISTS
Rupak Doshi, PhD, Co-Founder and CEO, OmniSync
Michael Dunn, PhD, Director of the Orthopaedic Research Laboratory, Rutgers Robert Wood Johnson Medical School
Dan Benderly, MBA: Associate Director of New Ventures, Rutgers Innovation Ventures

MODERATOR
Mark DeGuzman, MBA, Manager of New Ventures, Rutgers Innovation Ventures

AGENDA

9:35 a.m. - 10:20 a.m.
Keynote Presentation

10:25 a.m. - 11:15 a.m.
Panel Discussion

11:20 a.m. - 12:00 p.m.
Innovation Ventures and other resources at the Office for Research (New Ventures, I-Corps, Commercialization Funding)